Category: Indian Pharmaceutical Industry

  • MNC Pharma Companies & the Indian Market

    “Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for Western patients who can afford this product, quite honestly. It is an expensive product, being an oncology product.” ~ Marijn Dekkers, Bayer Chief Executive Officer…

  • Indian Pharma – A case of regulatory failure?

    Indian pharmaceutical companies cannot be judged by American standards. – GN Singh, Drug Controller General of India [source] If you are looking for one reason for the mess that the Indian pharma industry is in, you do not need to look further than the statement above. This is a statement made by the head of…